Background: We propose a set of criteria for diagnosis of intracranial infectious aneurysm (IA). The proposed diagnostic criteria contain a mandatory criterion (demonstration of intracranial aneurysm by neuroimaging) and twelve supportive criteria drawn from three domains. Domain A encompasses infection, such as infective endocarditis, meningitis, cavernous sinus thrombophlebitis, or orbital cellulitis. Domain B encompasses angiographic features of the aneurysm, such as multiplicity, distal location, fusiform shape, change in size or appearance of new aneurysm at follow-up angiogram. Domain C encompasses other features, such as age < 45 years, recent history of fever, lumbar puncture or cerebral hemorrhage. Each criterion is given one point and the sum under each domain (A sum , B sum and C sum ) and total score are calculated. Methods: We evaluated these criteria in 25 patients with confirmed IA and another 111 consecutive patients with non-infectious aneurysm. The sensitivity, specificity and receiver operator characteristic (ROC) curves were calculated for these cohorts. Results: The highest ROC was for total score (.997). A total score = 3 had high sensitivity (96%) and specificity (100%), as well as a positive predictive value of 100%, and negative predictive value of 99.4%. A total score = 2 had high sensitivity (100%) but low specificity (87.4%). Other combinations had lower ROC areas, sensitivities and specificities. Conclusion: Diagnosis of IA would be clinically compelling if three or more of the proposed supportive criteria are satisfied or clinically probable if two proposed supportive criteria are satisfied besides the mandatory criteria.
INTRODUCTION
Intracranial infectious aneurysm (IA) is a rare but potentially life-threatening condition. It accounts for 0.7 to 6.5% of all intracranial aneurysms according to different series 1, 2 . IA occurs due to destruction of the vessel wall secondary to infection of a segment of the artery. Spread of infection can be endovascular 3 , as in infective endocarditis (IE), or via extravascular contiguous spread 3, 4, 5, 6 , as in meningitis or cavernous sinus thrombophlebitis (CST). Rarely, it can occur from an unknown source (cryptogenic type). IA carries a high mortality 7 . Hence, it is very important to make an early diagnosis and initiate treatment on an emergent basis. Because IA is a rare disease, a high index of suspicion is essential to ensure its prompt diagnosis. In this context, it is essential to have a simple and reliable set of criteria for the diagnosis. However, establishing the diagnosis of IA is often difficult. The gold standard currently involves demonstration of the presence of an infectious organism along with inflammatory-mediated destruction of the vessel wall. This histopathological standard, though ideal, is fulfilled in < 20% of the cases in the published series and is possible only when IA is excised during surgery or when examined during autopsy 8 .Even then, fibrosis may be the only appreciable pathologic manifestation, especially if the IA is resected after prolonged antimicrobial treatment. Histological confirmation is rather retrospective as the specimen becomes available only after surgical intervention or death of the patient. This standard is therefore difficult to apply in a strictly clinical context in which there is a need to guide management, but a tissue-based diagnosis is not possible. There is a need for reliable and simple diagnostic criteria that can be applied early to select patients for different treatment protocols such as medical management, intervention procedures or surgery.
Unfortunately, at the present time, the clinical diagnosis of IA is incomplete; it is based on documentation of the aneurysm by angiography in the context of a predisposing infection such as IE, meningitis, or CST. (see figure 1 ) This standard is general and nondiscriminatory, and may lead to either over diagnosis (as could occur when a pre-existing berry aneurysm is incidentally detected in the context of a relevant infectious disease), or under diagnosis (when the infection is not obvious or the aneurysm is atypical). Both of these issues could potentially be addressed by considering additional data in the diagnostic work-up. After reviewing both our own clinical material as well as the published literature, we have developed and validated a new set of criteria for the clinical diagnosis of IA.
( Figure 1 near here)
METHODS
This study was carried out at Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), in Trivandrum, South India, which is a tertiary care center for neurological and cardiac disorders. The institution's emphasis on cerebrovascular disease provided us the opportunity to care for a large number of patients with infectious intracranial aneurysms during the past three decades.
Patients
Two cohorts of patients were identified by retrospective case review, and utilized to both develop and validate our proposed criteria. 
Identification of salient clinical data
We abstracted relevant clinical characteristics for each patient on to a standardized proforma. Data were transferred to a spreadsheet and appropriate descriptive statistics were calculated. The data were further analyzed with SPSS version 14 (SPSS Inc. Chicago, IL, USA) to calculate sensitivity, specificity and generate Receiver Operator Characteristic (ROC) curves. Positive and negative predictive values of the proposed criteria were calculated using the prevalence of 1.44% for IA calculated as described above.
Diagnostic criteria
We had generated a set of discriminative clinical criteria by analyzing permutations of relevant clinical data and comparing the resultant clinical predictive ability of each combination (see below). The proposed diagnostic criteria we developed include a mandatory criterion (demonstration of an intracranial aneurysm by neuroimaging) and 12 supportive criteria drawn from three domains ( Table 2) . Each positive supportive criterion is given one point. The score under each domain (A sum , B sum and C sum ) as well as the total score were calculated for each patient. Category scores were calculated for each domain as one, if the sum score for that domain was equal to or greater than one. 
RESULTS
The total score for the IA group ranged from 2 -6 (mean 4.68 + 1.03, median 5) while that for non-IA group ranged from 0 -2 (mean 0.73 + 0.67, median 1). The mean A sum for the IA was 1.2 + .5 and for non IA was 0. The mean B sum for IA was 1.16 + .62 and for Non IA group was .27 + .49. The mean C sum for IA was 2.32 + .75 and for non IA was .46 + .58. These differences were statistically significant (p< 0.0001). ROC curve analyses for various combinations of salient characteristics were generated. The area under the ROC curve, sensitivity and specificity for each domain and score are given in table 3. A score of one under domain A had high sensitivity and specificity but did not have the best area under the ROC curve and hence it was excluded from further analysis. The ROC curve area was highest (0.997) for the total score (Figure 2 ) when compared to that for the sum for different domains (table 3). The category scores alone did not yield useful ROC, sensitivity or specificity scores (data not shown). A total score of three had maximum sensitivity (96%) and specificity (100%), as well as a positive predictive value of 100% and negative predictive value of 99.4%. A cut-off value of two for the total score had high sensitivity (100%), but its specificity was comparatively low (87.4%). For a total score of one, the sensitivity and specificity for a diagnosis of IA were 100% and 39.6%, respectively. 
DISCUSSION
The diagnosis of IA requires a high index of suspicion. Currently, the diagnosis of IA is suggested in an appropriate clinical context, but a definitive diagnosis is possible only when a pathologic specimen is available or at autopsy. Previously, there have been no proposed or validated criteria to clinically diagnose IA. In this study, we have proposed a simple schema, consisting of one mandatory criterion with 12 supportive criteria under three major domains (predisposing infection, angiographic findings and other features contributing to diagnosis). Our results indicate that a total score of three or more, regardless of the domain, has high specificity, sensitivity (96%), and positive and negative predictive value for the diagnosis of IA. We therefore propose that a total score of three is confirmative of clinically definitive IA. (see table 4) A total score of two would be consistent with clinically probable IA with a sensitivity and specificity of 100% and 87.4% respectively. For total score of one, the sensitivity and specificity for the diagnosis of IA are 100% and 39.6% respectively, consistent with possible IA. Although A sum scores with a cut-off value of one also had high sensitivity (96%) and specificity (100%), we chose to rely on total scores for diagnosis as it had the highest area under the ROC curve. ROC curve characteristics have several advantages over sensitivity and specificity while evaluating the precision of a diagnostic test. ROC curve is more comprehensive and precise than sensitivity and specificity in assessing the usefulness of a new test. The main limitation of this study is that histological confirmation of IA was limited to 20% in the series that we used for this analysis. As mentioned earlier, histological proof is not possible in several instances. We would like to emphaise that these proposed criteria require further testing and validation on a different sample of data. Prior reports on IA have included cases using solely clinical criteria, with a lower proportion of biopsy-proven cases 1, 3, 4, 9, 10 . We have extended this approach and selected several characteristics typical of IA drawn from clinical, imaging and other domains while preparing this proposed set of criteria. Our IA cohort consisted of 25 cases of IA of diverse clinical profiles. There were five cases of biopsy proven IA, one that showed a new aneurysm on follow-up angiogram, six cases that revealed a change in size of the aneurysm on follow-up angiogram, and seven cases where the IA resolved with medical therapy. These features further strengthen the diagnosis of IA in the patients included in the IA cohort. In general, the patients with IA were younger and exhibited disease in locations atypical for berry aneurysm (Table 1) .
Chapot et al¹ used the following criteria to include patients in their study of the endovascular treatment of IA. The presence of endocarditis and a positive blood culture were the core features for diagnosis. Each aneurysm had to either involve segments 2, 3 or 4 of the middle cerebral artery or the posterior cerebral artery or involve segments M1 or P1 in association with at least 2 of the following criteria: a) change in aneurysm size or morphology on consecutive angiograms b) presence of another intra-or extra-cranial mycotic aneurysm c) rupture of the aneurysm d) arterial occlusion or stenosis adjacent to the aneurysm e) cerebral infarction due to arterial occlusion at the level of the lesion.
Drawbacks of these criteria include the limitation of relevant infectious diseases to IE alone. In addition, these rules exclude all other predisposing factors, especially extravascular ones. Furthermore, these criteria insist on microbial culture positivity, a condition that restricts the applicability to less than half of IA in general. Organisms are isolated in only 30% to 47 % of IA. 9, 10 Also excluded are aneurysms located in the anterior cerebral artery or vertebrobasilar circulation.
The cohort that we used in this study was large, contained a variety of etiologies, (bacterial, fungal, tubercular organisms) and predisposing conditions (infective endocarditis, meningitis, and cavernous sinus thrombophlebitis). Hence, the proposed criteria are applicable to IAs of both intravascular (i.e., IE related) and extravascular (i.e., meningitis, CTS, orbital cellulitis) origin. They include aneurysms in all locations within the CNS, and take into account 12 parameters to provide wider clinical generalizability. One possible advantage of these proposed criteria is that they can be applied even in the absence of microbial isolation. The diagnosis of cryptogenic IA is more challenging, since one important criterion (presence or history of predisposing infection) is lacking in such instances. However, with these criteria, we could diagnose clinically definite IA in the only case of cryptogenic IA in our series. The strength of these criteria to diagnose cryptogenic IA needs confirmation in another set of data from a different background. We included fever or history of recent fever of one or more weeks' duration in domain three. This strategy enabled us to include other infections pneumonia or other sepsis that may possibly contribute to the pathogenesis of IA. 
CONCLUSION
The proposed criteria appear to be reliable and easily applicable to a wide range of IA patients. It is likely to have wider generalizability as is based on analysis of all subtypes of IA including cryptogenic variant. Its clinical validity and reliability needs to be further confirmed. This set of diagnostic criteria would probably be very useful in clinical research and practice. Its clinical reliability needs further confirmed by validation on another set of IA under different settings.
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